These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
45. Electriptan in acute migraine: A double-blind, placebo-controlled comparison to sumatriptan. Spierings EL Neurology; 2000 Sep; 55(5):735; author reply 736. PubMed ID: 10980753 [No Abstract] [Full Text] [Related]
46. The name of a drug used for the treatment of migraine. Mattsson P Eur J Public Health; 2002 Jun; 12(2):155. PubMed ID: 12073756 [No Abstract] [Full Text] [Related]
47. A 27-year-old woman with migraine headaches, 1 year later. Daley J; Delbanco TL; Hartman EE JAMA; 1998 Mar; 279(12):954. PubMed ID: 9544771 [No Abstract] [Full Text] [Related]
48. Issues relating to the assessment of migraine recurrence following triptan therapy. Millson D; Tepper S Eur J Neurol; 1999 Jul; 6(4):525-6. PubMed ID: 10362912 [No Abstract] [Full Text] [Related]
49. Have the triptans fulfilled their promise? Zagami AS J Clin Neurosci; 2001 Sep; 8(5):476-7. PubMed ID: 11535025 [No Abstract] [Full Text] [Related]
51. Sumatriptan 6 mg subcutaneous as an effective migraine treatment in patients with cutaneous allodynia who historically fail to respond to oral triptans. Diamond S; Freitag FG; Feoktistov A; Nissan G J Headache Pain; 2007 Feb; 8(1):13-8. PubMed ID: 17221340 [TBL] [Abstract][Full Text] [Related]
52. Sumatriptan nasal spray in the acute treatment of migraine: a review of clinical studies. Tfelt-Hansen P Cephalalgia; 2000 Mar; 20(2):137. PubMed ID: 10961773 [No Abstract] [Full Text] [Related]
54. Managed migraine. Hasegawa E Am J Health Syst Pharm; 1999 Nov; 56(21):2193. PubMed ID: 10565697 [No Abstract] [Full Text] [Related]
55. Profiles of 5-HT 1B/1D agonists in acute migraine with special reference to second generation agents. Deleu D; Hanssens Y Acta Neurol Belg; 1999 Jun; 99(2):85-95. PubMed ID: 10427351 [TBL] [Abstract][Full Text] [Related]
56. Chest symptoms after sumatriptan: a two-year clinical practice review in 735 consecutive migraine patients. Visser WH; Jaspers NM; de Vriend RH; Ferrari MD Cephalalgia; 1996 Dec; 16(8):554-9. PubMed ID: 8980858 [TBL] [Abstract][Full Text] [Related]
57. Triptan therapy in migraine. Loder E N Engl J Med; 2010 Jul; 363(1):63-70. PubMed ID: 20592298 [No Abstract] [Full Text] [Related]
58. Relief for menstruation-related migraines. Cockey CD AWHONN Lifelines; 2002 Dec; 6(6):497. PubMed ID: 12593251 [No Abstract] [Full Text] [Related]
59. Immunological aspects in migraine: increase of IL-10 plasma levels during attack. Munno I; Marinaro M; Bassi A; Cassiano MA; Causarano V; Centonze V Headache; 2001 Sep; 41(8):764-7. PubMed ID: 11576199 [TBL] [Abstract][Full Text] [Related]